Total Funding
78
71
Total FundingSeries A raised
Growth Score
-13 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4516
PhaseV provides AI-driven solutions for efficient clinical development and operations.
- Raviv Pryluk: CEO and Co-Founder
- Dan Goldstaub: Co-FounderPast Role: Tiltan Pharma, COO
About the Company
PhaseV offers AI-driven solutions that enhance clinical development for biopharma sponsors and contract research organizations (CROs). The company focuses on utilizing machine learning to streamline clinical operations, improving the processes of feasibility assessments and site selection. By providing data-driven insights, PhaseV helps clients
make informed decisions that accelerate trial timelines. Their innovative approach aims to transform traditional methods in clinical research, contributing to more efficient and effective drug development. With a commitment to integrating technology into clinical trials, PhaseV plays a significant role in advancing the pharmaceutical industry's operational capabilities.
